U.S. Officials Clear COVID-19 Jab For Infants, Preschoolers
The first COVID-19 vaccines for newborns and preschoolers were approved by US regulators on Friday, June 17, paving the path for inoculation to begin...
FDA Officials Support Moderna, Pfizer COVID-19 Jabs For Kids
Parents may soon be allowed to line up their children for vaccinations after Pfizer and Moderna's COVID-19 vaccine application for young children progresses through...
FDA Not So Fast On Approval Of The Novavax COVID-19 Vaccine
The US handed Novavax a $1.6 billion funding 4 months into the pandemic, in July 2020, to speed the biotech's research of a coronavirus...
FDA Rebukes Althera On Cholesterol Medication Assertions
Althera Pharmaceuticals, a producer of cardiovascular drugs, is being investigated by the FDA for its cholesterol oral delivery medicine, Roszet. The FDA's Office of...
Rejected By The FDA, NICE Endorses The Anaemia Drug Evrenzo
Despite a high-profile FDA denial, FibroGen and its collaborators have been able to expand into new markets outside of the United States with Evrenzo,...
Bluebird Gene Therapy Given FDA Nod Despite Safety Issues
Bluebird bio has persuaded an expert committee that the benefits of its gene therapy possibility, eli-cel, exceed the risks, at least in certain patients,...
Bispecific Blood Cancer Drug By Roche Globally Approved
Roche is exploring new products to refill its blood cancer armoury after Rituxan's patent expiration. Swiss pharma is launching a novel bispecific lymphoma medicine...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...